30 likes | 42 Views
US drug discovery informatics market is estimated to grow significantly of 10.6% during the forecast period. The growing drug discoveries are primarily boosting the demand for drug discovery analytics solutions to properly conduct genome researches in the country.
E N D
Orion Market Research US Drug Discovery Informatics Market, Size, Share, Analysis Report & Forecast to 2026 To Market: https://www.omrglobal.com/request-sample/us-drug-discovery-informatics-market Request a Sample of our Report on US Drug Discovery Informatics Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404
US drug discovery informatics market is projected to grow at a significant CAGR during the forecast period (2020-2026). The significant presence of major pharmaceutical companies such as Pfizer Inc., AbbVie Inc., Eli Lilly & co., and others coupled with significant adoption of analytics solutions further provides a significant opportunity to the market. Moreover, the growing research for personalized medicine in the country is encouraging the demand for drug discovery analytics among pharmaceutical companies in the country. The US FDA had received a significant number of applications relating to the approval of personalized medicines over the past years. (Get 15% Discount on Buying this Report) A at: https://www.omrglobal.com/industry-reports/us-drug-discovery-informatics-market full Report of US Drug Discovery Informatics Market is Available The Personalized Medicine Coalition has classified 28% of new molecular entities (NMEs) as personalized medicines in 2015, and 42% in 2018, in the US. The growing FDA approvals signify the considerable existence of researches working towards the development of personalized medicine. Personalized medicine formation requires patient-specific data to create therapeutic strategies for individual patients. In the overall process of personalized medicine formation, a large amount of data gets generated which when analyzed have the potential to enable the diagnosis, treatment, and prevention of disease at a highly personalized level. Therefore, an increase in the number of researches related to the development of personalized medicine in the country is making a considerable scope for the US drug discovery informatics market. To Market: https://www.omrglobal.com/request-sample/us-drug-discovery-informatics-market Request a Sample of our Report on US Drug Discovery Informatics US Drug Discovery Informatics Market – Segmentation By Function •Docking •Molecular Modeling •Libraries and Database Preparation •Sequencing and Target Data Analysis •Others By End-User •Pharmaceutical & Biotechnology Companies •Contract Research Organization (CRO) •Others (Research Institutes) Company Profiles •Albany Molecular Research Inc. •Charles River Laboratories, Inc. •ChemBridge Corp. •Clarivate Analytics •Certara, L.P. •Cognizant
•Collaborative Drug Discovery Inc. •IBM Corp. •OpenEye Scientific Software •PerkinElmer Inc. •Schrödinger, LLC Reasons to Buying From us – 1. We cover more than 15 major industries, further segmented into more than 90 sectors. 2. More than 120 countries are for analysis. 3. Over 100+ paid data sources mined for investigation. 4. Our expert research analysts answer all your questions before and after purchasing your report. For https://www.omrglobal.com/report-customization/us-drug-discovery-informatics-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. More Customized Data, Request for Report Customization @ For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 7803040404